Spa Spa DPC = 1.22 DPC -30.3 =1.00ER155 + 63.4 =0.80 ER155 + 82.0 <0.0005 <0.0005 not sign. 62.3 0.950 32.7 0.989 68.5 0.940 43 42 43 -13.2 <0.0005 51.4 0.975 41 -107 <0.0005 56.8 0.966 41 + 5.60 <0.0005 50.7 0.983 42 SpecImentype Mean Fructosamine, mmol/L So 55.2 0.979 68.0 0.969 81.9 0.966 62.7 0.972 41 43 42 43 We compared the TestpackT" hCG-Serum (Abbott Laboratories) and the TandemTM IcoN'TM(Hybritech, Inc.) two-site, monoclonal-antibody, immunoenzymatic qualitative assays for serum choriogonadotropin (hCG). Both kits had a performance time of 5 mm and sensitivities of approximately 20 mt. units/L (calibrated with 2nd Int. Standard hCG).
whereas ER 155(+) gave higher results (P <0.0005) than the IH( + ) did.
We conclude that: (a) direct assays intercompare rather well but (b) give higher results following extraction; (c) some ofthe direct assays-Spectria and DPC-are more suited for use with extraction (like ER 150) than other techniques (e.g., ER 155) ifcompared with IH(+). We thank the companies and their representatives for the donation of the test kits. Blood was sampled from healthy volunteers (lab. personnel, three men and 13 women) into plain tubes and into tubes containing lithium heparin, Na fluoride/potassium oxalate, or EDTA (Becton Dickinson, Rutherford, NJ 07070). The resulting sera and plasmas were analyzed for fructosamine on the day of collection in an IL Multistatifi, measuring absorbance at 520 nm at 37 #{176}C. Roche reagent and standards (0.77, 2.96, 5.22 mmoliL) were used as recommended.
Effect of Anticoagulants on Fructosamine
The reaction mixture consisted of 15 L of sample, 150 .tLof reagent, and 40 1zL of distilled water. A human albumin blank (40 g/L in isotonic saline) ensured a linear standard curve through zero. Within-run precision of the method (CV) was 0.73% at 2.89 mmol/L (n 17). Plasmas prepared with all anticoagulants tested gave lower results for fructosamine than did serum. For EDTA, the t-value (2.126) just failed to achieve statistical significance (critical t-value atP = 0.05 is 2.131). The lower results for fructosamine in NaF/K oxalate plasma than in serum are opposite to the marginally higher results for fructosemine observed by Baker et al. on the addition offluoride or oxalate to serum. This discrepancy can be explained by the significant water shift from erythrocytes to plasma that occurs in blood containing these anticoagulants. On the other hand, heparin and EDTA evidently give lower results for fructosamine either when added to serum or when used directly as anticoagulants.
Differences between mean fructosamine concentrations of
In this study, I observed somewhat higher reference values (2.6-3.1 mmolIL) for serum fructosamine than expected by the manufacturer (2.0-2.8 mmoL'L). This is probably a consequence of the lower-than-recommended final concentration ofnitroblue tetrazolium chloride (NET, 183 vs 227 zmolIL) in the reaction mixture, owing to the requirement for wash water in the sample/reagent dispensing cycle of the Multistat loader. Baker et al. found the fructosamine assay to be sensitive to the concentration of NBT.
Fructosamine assay may frequently be requested with glycated hemoglobin and glucose, tests that usually require specimens treated with EDTA and NaF/K oxalate, respectively. Accordingly, analysts should ensure that fructosemine is measured in specimens for which appropriate reference intervals are available.
The fructosamine kits were kindly supplied by Roche Products (New Zealand) Ltd. units/L, 100% specificity, and rapid performance time make these excellent tests for the detection ofearly pregnancy and the diagnosis of ectopic pregnancy.
Two Rapid, Sensitive, and Specific lmmunoenzymatic

Results with a Fructosamine Kit for a Group of Diabetics in Southeast Asia, L. L. Tho,' E. S. C. Koay,'
A. C. Thai,2 and J. K. Candlish'3 (Depts. 1 Biochem. and 2 Med., National University of Singapore, Kent Ridge, Singapore 05i i ; address correspondence to this author)
The original suggestion (1) to measure glycation of proteins with shorter circulating half-lives than hemoglobin has been widely adopted, and a kit (Fructosamine Test, Roche) based on the ability ofplasma protein-sugar adducts to reduce nitroblue tetrazolium under alkaline conditions was marketed. We assessedthis kit, using a population of 67 diabetics attending an outpatient clinic in Singapore.
Day-to-day imprecision was considered to be acceptable in that the CV did not exceed 4.3% for the concentrations tested.
A population of 104 apparently healthy subjects showed a gaussian distribution of fructosamine values, and by plots on cumulative frequency paper the data yielded a reference interval of 1.9-2.9 mmol/L. In addition, six healthy subjects gave blood at five different times of day on four separate days at weekly intervals to allow calculation of intraindividual as well as analytical variances (from duplicate assays) and therefore Harris ratios (2), which ranged from 0.23 to 1.2,suggesting that itis better to use the individual as his own referent for this assay.
In the diabetics, who were non-fasting, fructosamine concentrations were compared with those for serum glucose, cholesterol, and triglycerides as well as glycated hemoglobin by two methods (Pierce Glycotest 4200 kit for "glycosylated (Figure 1) . We conclude that, in the population we examined, as in others (3), fructosamine assay represents a valuable index of hyperglycemia when retrospection over a shorter period than for glycated hemoglobin is deemed desirable. EC 4.1.3.6) is added, to decomposeany oxaloacetate and pyruvate present in the sample. The small decrease in absorbance monitored at 340 run was complete within 180 s. The citrate lyase reaction was complete within 60 s. NADH oxidation, momtored at 340 run, is stoichiometrically related to the amount of citrate.
Citrate in Urine Estimated by a Citrate Lyase Technique
The reagents were reconstituted according to the manufacturer's instructions.
The following settings were used in the analyzer: unit, minoL/L: calculation factor, 0; standard 1, 2.10 mmol/L; standard 2, 1.05 mmollL; standard 3, 0.505 mmol/L; temperature, 37 #{176}C; type ofanalysis, 6; wavelength (nm), 340; sample volume (pL), 10; diluent volume (ML), 40; reagent volume (ML), 250; incubation time (s), 180; start reagent volume (ML), 5; time of first reading (s), 0.5; number of readings, 6; time intervals (s), 10; blanking mode, 0; print out mode, 1.
